Published in Gynecol Oncol on December 25, 2013
Retrotransposon-based profiling of mammalian epigenomes: DNA methylation of IAP LTRs in embryonic stem, somatic and cancer cells. Genomics (2014) 0.91
DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Epigenetics (2015) 0.81
DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer. Mol Cancer Res (2016) 0.81
DNA methylation changes in epithelial ovarian cancer histotypes. Genomics (2015) 0.80
Disagreement between two common biomarkers of global DNA methylation. Clin Epigenetics (2016) 0.80
LINE-1 in cancer: multifaceted functions and potential clinical implications. Genet Med (2015) 0.79
Methylated Cytosines Mutate to Transcription Factor Binding Sites that Drive Tetrapod Evolution. Genome Biol Evol (2015) 0.76
DNA methylation variation of human-specific Alu repeats. Epigenetics (2016) 0.76
PRAME expression and promoter hypomethylation in epithelial ovarian cancer. Oncotarget (2016) 0.75
Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment. PLoS One (2017) 0.75
Performance of Different Analytical Software Packages in Quantification of DNA Methylation by Pyrosequencing. PLoS One (2016) 0.75
CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel. Clin Epigenetics (2017) 0.75
Oxidative stress and repetitive element methylation changes in artisanal gold miners occupationally exposed to mercury. Heliyon (2017) 0.75
Alu repeats and human genomic diversity. Nat Rev Genet (2002) 12.40
A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer (2011) 11.33
A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res (2004) 7.92
DNA methylation in cancer: too much, but also too little. Oncogene (2002) 6.96
Chromosomal instability and tumors promoted by DNA hypomethylation. Science (2003) 6.02
Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2007) 4.01
The cell of origin of ovarian epithelial tumours. Lancet Oncol (2008) 3.74
Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol (2008) 3.60
The impact of L1 retrotransposons on the human genome. Nat Genet (1998) 3.56
Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene (2004) 3.50
An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One (2009) 3.33
LINE-1: a mammalian transposable element. Biochim Biophys Acta (1987) 2.63
Frequent human genomic DNA transduction driven by LINE-1 retrotransposition. Genome Res (2000) 2.60
Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis (2009) 2.58
Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet (2010) 2.27
Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology (2003) 2.21
Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res (2005) 2.19
Global methylation profiles in DNA from different blood cell types. Epigenetics (2011) 1.94
Epigenetic resensitization to platinum in ovarian cancer. Cancer Res (2012) 1.88
DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer (1999) 1.86
Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis. Jpn J Clin Oncol (2000) 1.84
Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology (2007) 1.83
Ovarian cancer pathogenesis: a model in evolution. J Oncol (2009) 1.77
DNA hypomethylation and ovarian cancer biology. Cancer Res (2004) 1.75
DNA methylation in development and human disease. Mutat Res (2008) 1.74
Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int J Colorectal Dis (2003) 1.69
Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) (2012) 1.61
Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One (2012) 1.43
Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Clin Cancer Res (2011) 1.38
Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut (2013) 1.37
A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer. Cancer (2010) 1.34
Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer. Clin Cancer Res (2008) 1.32
Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res (1996) 1.24
Differential repetitive DNA methylation in multiple myeloma molecular subgroups. Carcinogenesis (2009) 1.18
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer. Cancer Immunol Res (2014) 1.01
Molecular-targeted therapies for ovarian cancer: prospects for the future. Int J Clin Oncol (2012) 0.99
Blood-derived DNA methylation markers of cancer risk. Adv Exp Med Biol (2013) 0.91
Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Genome-wide hypomethylation and cancer risk--letter. Cancer Prev Res (Phila) (2013) 0.87
Methods for cancer epigenome analysis. Adv Exp Med Biol (2013) 0.80